Remidio at the Jalandhar Ophthalmological Society CME, discussing myopia management and showcasing the Pristine OBM 12 for axial length and corneal radius measurement and monitoring myopia progression.
#Myopia #Ophthalmology #Remidio
At #NationalHealthInnovationConclave2026, Remidio’s Dushyantsinh Anopsinh Jadeja will share perspectives on applying AI and technology to real-world healthcare challenges.
#HealthcareInnovation #DigitalHealth #Remidio
At #APOIS2026, Dr. Divya Rao joins as an Industry Presenter to discuss how oculomics can move from clinical evidence to real-world practice.
📅 Oct 31 | 15:30–17:00
📍 Grand Walkerhill Seoul
#Oculomics #Remidio
ANI’s feature highlights Remidio’s work in portable retinal imaging and AI-assisted eye screening, as part of its story on young innovators bringing AI and wearable technology to healthcare.
Read more: aninews.in/news/national/gen…
#Remidio #EyeCare
In @TheWeekLive, Remidio’s Dr. Divya Rao explores how AI-powered oculomics could help identify kidney and cardiovascular disease risks earlier through retinal imaging.
Read more: theweek.in/news/health/2026/…
#Oculomics #EyeCare #Remidio
This Dussehra, Remidio continues its work to prevent avoidable blindness through AI-driven diagnostics and explore wider health insights through Oculomics. Here’s to early detection and better health.
Wishing you and your family a happy Dussehra!
#HappyDussehra #EyeHealth
Remidio at WOS 2026, New Delhi. Dr. Jitendra Jethani led a workshop on myopia management, engaging with clinical perspectives on eye care.
Designed in India. Deployed for the World.
#WOS2026 #Ophthalmology #Remidio
Remidio featured on ANI Bharat! The feature explores how portable eye imaging and AI-enabled screening can help detect eye conditions early, making eye care more accessible.
Thanks to ANI Bharat.
Watch: youtube.com/watch?v=pCJChsl5…
Remidio featured on DD News, highlighting our work in portable eye imaging and AI-enabled screening.
Thank you to Ashutosh Dhar Dubey and DD News for covering our work.
#Remidio #EyeCare #AIinHealthcare
#NextGenBharat | Young innovators are transforming healthcare with AI-powered eye scans to detect disease risks in Bengaluru and smart wearable devices offering heat and vibration therapy for arthritis patients in Jodhpur.
Watch Full Program: youtu.be/tLFikgi-AEw
@ANI #AI #Jodhpur #Bengaluru #Healthcare
Myopia management is a growing focus in paediatric eye care. Join Dr. Jitendra Jethani at WOS 2026 for a workshop on myopia management.
📍 Hall C, InterContinental Eros, New Delhi
📅 16 Oct | 12:15–1:15 PM
#WOS2026 #MyopiaManagement #Remidio
Remidio at #AAO2026 in New Orleans. We showcased our innovations, connected with the global ophthalmology community and exchanged perspectives on AI and the future of eye care.
Designed in India. Deployed for the World.
#Ophthalmology #EyeCare #Remidio
Good vision plays an important role in how children read, learn and participate at school, which is why regular eye checks are important to identify vision problems early and support timely care.
#WorldSightDay #LoveYourEyes #ChildEyeHealth #Remidio
One portfolio. A broader vision for eye care.
Remidio at #AAO2026. Explore Insta FOP, Insta Ref, Insta PSL, Insta KC, InstaZ, OBM 12 and Insta Neubo 130 at Booth 3218 in New Orleans, October 9–12.
#Remidio #Ophthalmology #AIinhealthcare
The ER moves fast.
At #ACEP26, Remidio is showcasing the InstaEyeClinic Kit with the InstaFOP, InstaPSL and Rebound Tonometer for eye assessment in emergency and bedside care.
Visit Booth 2915 in Chicago, October 5–8.
#EmergencyMedicine #EyeCare #Remidio
Remidio at the Digital Health Conclave 2026 in Ranchi.
Our team spoke about the role of AI and advanced diagnostics in early screening for eye, heart, and kidney health.
Watch the conversation from the conclave.
#DigitalHealth #EyeCare #MedTech #Remidio
This Gandhi Jayanti, we remember a vision of India where progress reaches everyone.
At Remidio, we’re using technology to expand access to better vision care and build a healthier future for every Indian.
A vision for India. A future in sight.
#HappyGandhiJayanti #Remidio
AI THAT MAKES RETINAL IMAGING SIMPLER.
NOW, PATENTED IN JAPAN.
Remidio has been granted a patent by the Japan Patent Office for an AI-based automated retinal imaging system that uses deep learning to automate retinal image capture.
By reducing the expertise required to capture retinal images and reducing dependence on hardware-based automation, the technology can help make retinal screening simpler, more accessible and easier to integrate into everyday clinical workflows.
Because AI goes beyond diagnosis.
It can also make eye care easier to deliver.
Read the full article → zurl.co/5KnXe












